<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Acute stroke management. In: Canadian best practice recommendations for stroke care.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Acute stroke management. In: Lindsay MP, Gubitz G, Bayley M, Hill MD, Davies-Schinkel C, Singh S, Phillips S, Canadian Stroke Strategy Best Practices and Standards Writing Group. Canadian best practice recommendations for stroke care. Ottawa (ON): Canadian Stroke Network; 2010 Dec 8. p. 85-98.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S. Canadian best practice recommendations for stroke care. CMAJ 2008 Dec 2;179(12 Suppl).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Best Practice Recommendations for Stroke Care include an ongoing plan to formally update the recommendations every 2 years to ensure that the best practice recommendations remain current and are coordinated with other similar initiatives nationally and internationally.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Cerebral artery occlusion, unspecified with cerebral infarction  (434.91); Fever, unspecified  (780.60); Functional evaluation  (93.01); General physical examination  (89.7); Neurologic examination  (89.13); Unspecified intracranial hemorrhage  (432.9); Urinary incontinence, unspecified  (788.30)"/><FieldValue Value="MSH: Activities of Daily Living ; Acute Disease ; Blood Chemical Analysis ; Blood Pressure Determination ; Body Temperature ; Body Temperature Changes ; Brain Ischemia ; Early Ambulation ; Fever ; Fluid Therapy ; Hospitalization ; Hospitals, Special ; Intermittent Urethral Catheterization ; Intracranial Hemorrhages ; Neurologic Examination ; Nutrition Assessment ; Nutrition Therapy ; Oximetry ; Palliative Care ; Patient Admission ; Patient Care Planning ; Patient Care Team ; Physical Examination ; Preventive Health Services ; Referral and Consultation ; Rehabilitation ; Stroke ; Terminal Care ; Thrombolytic Therapy ; Time Factors ; Urinary Incontinence ; Venous Thromboembolism "/><FieldValue Value="MTH: Activities of Daily Living (activity) ; Blood Chemical Analysis ; Blood glucose measurement ; Blood pressure determination ; Body Temperature ; Body Temperature Changes ; Brain hemorrhage ; Brain Ischemia ; Cerebrovascular accident ; Fever ; Fluid Therapy ; Hospitalization ; Hydration status ; Ischemic stroke ; Neurologic Examination ; Nutrition Assessment ; Nutrition Therapy ; Oral assessment panel ; Oral care given ; Oxygen saturation measurement ; Palliative Care ; physical examination ; Rehabilitation therapy ; special hospital ; terminal patient care ; Thermoregulation measures ; Urinary bladder training ; Urinary Incontinence ; Venous Thromboembolism "/><FieldValue Value="PDQ: thrombolytic therapy ; urinary incontinence "/><FieldValue Value="SNOMEDCT_US: Activity of daily living  (129025006); Acute disease  (2704003); Admission to stroke unit  (306803007); Assessment of nutritional status  (1759002); Assessment of nutritional status  (310243009); Blood chemistry  (166312007); Blood pressure taking  (46973005); Body temperature  (105723007); Body temperature  (386725007); Body temperature modification and control  (180333002); Bowel training management  (385977004); Cerebral artery occlusion  (20059004); Cerebrovascular accident  (230690007); Dying care  (182964004); Dying care  (385736008); Fever  (386661006); Fever  (50177009); Functional assessment  (12894003); Glucose measurement, blood  (33747003); Hydration status  (405006006); Initial patient assessment  (315639002); Inpatient care  (394656005); Intermittent urethral catheterization  (225103006); Intracranial hemorrhage  (1386000); Ischemic encephalopathy  (389100007); Ischemic stroke  (422504002); Neurological assessment  (225398001); Neurological assessment  (84728005); Nutrition therapy  (386373004); Oxygen saturation measurement  (104847001); Oxygen saturation measurement  (264598005); Palliative care  (103735009); Physical assessment  (302199004); Physical assessment  (5880005); Physical assessment  (81375008); Rehabilitation therapy  (52052004); Special hospital  (288561005); Stroke prevention  (135875009); Stroke rehabilitation  (2517002); Stroke unit  (309966001); Thrombolytic therapy  (426347000); Urinary bladder training  (37799002); Urinary incontinence  (165232002)"/><FieldValue Value="UMD: Physiologic Monitor Modules, Pulse Oximetry  (20-781); Procedure Kit/Trays, Catheterization, Urinary, Intermittent  (16-321)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Acute stroke or transient ischemic attack&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Management" /><FieldValue Value="Prevention" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Critical Care" /><FieldValue Value="Dentistry" /><FieldValue Value="Emergency Medicine" /><FieldValue Value="Family Practice" /><FieldValue Value="Geriatrics" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Neurology" /><FieldValue Value="Nursing" /><FieldValue Value="Nutrition" /><FieldValue Value="Pediatrics" /><FieldValue Value="Physical Medicine and Rehabilitation" /><FieldValue Value="Preventive Medicine" /><FieldValue Value="Psychology" /><FieldValue Value="Speech-Language Pathology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Allied Health Personnel" /><FieldValue Value="Dentists" /><FieldValue Value="Dietitians" /><FieldValue Value="Emergency Medical Technicians/Paramedics" /><FieldValue Value="Health Care Providers" /><FieldValue Value="Hospitals" /><FieldValue Value="Nurses" /><FieldValue Value="Occupational Therapists" /><FieldValue Value="Patients" /><FieldValue Value="Pharmacists" /><FieldValue Value="Physical Therapists" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /><FieldValue Value="Psychologists/Non-physician Behavioral Health Clinicians" /><FieldValue Value="Social Workers" /><FieldValue Value="Speech-Language Pathologists" /><FieldValue Value="Utilization Management" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To provide a synthesis of best practices in stroke care across the continuum of care and serve as a framework for Canadian provinces and territories as they develop and implement stroke strategies&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;All patients admitted to the hospital because of an acute stroke or transient ischemic attack&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Assessment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evaluation of impairment and functional status &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment for risk of developing venous thromboembolism &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Monitoring of body temperature and assessment for fever related to complications of stroke &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Monitoring of blood pressure, oxygen saturation, blood glucose &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for urinary incontinence &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of nutritional and hydration status &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Oral/dental assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Early assessment by a rehabilitation professional &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Management&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patient admission to an interprofessional stroke unit &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Initial patient assessment within 48 hours of admission &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management plan development &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Child admission and management by center with paediatric stroke expertise &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prevention of and management of complications &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Venous thromboembolism prophylaxis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Temperature management &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Mobilization as early as possible &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Bladder training, intermittent catheterization and bowel management programs &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutritional and fluid support &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Oral care and referral to dentist &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Advanced care planning &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Palliative end-of-life care &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xA;    &lt;li&gt;Institutionalized care or dependency &lt;/li&gt;&#xA;    &lt;li&gt;Death &lt;/li&gt;&#xA;    &lt;li&gt; Reliability of standardized validated tools&lt;/li&gt;&#xA;    &lt;li&gt;Risk of thromboembolism and other complications of stroke &lt;/li&gt;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Literature Search&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;MEDLINE, EMBASE and the Cochrane Library databases were rigorously searched. Also, the grey literature and websites of other best practice recommendation developers were searched for relevant material that may not have been published in an academic journal.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The time frame of each literature search ran from the time the best practice recommendation was last updated (2008) up until September, 2010. Unless invalid, the literature from the previously reviewed recommendations, completed in 2006 and 2008, was included. For new recommendations, the literature search time frame was from 1990 until September, 2010.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The following studies were included during the search: randomized controlled clinical trials (double-blinded or nonblinded); meta-analyses of randomized studies; nonrandomized controlled clinical trials and case series; population-based, consecutive series; consecutive cases (not population-based); or, non-consecutive cases. Included articles were published in English and were based on human studies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All terms used were particular to stroke and the topic being searched. A total of 35 different topics were explored. Specific drug names, treatment names, and therapy names were used to create an inclusive database for each topic. This resulted in a total of 699 references included in the Canadian Stroke Best Practice Recommendations 2010 update.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A total of 699 studies were included.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Expert Consensus" /><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Summary of Definitions for Levels of Evidence*&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Rating Scheme for the Strength of the Evidence&quot; cellpadding=&quot;3&quot; width=&quot;50%&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Criteria&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Strong recommendation. Evidence from randomized controlled trials or meta-analyses of randomized controlled trials. Desirable effects clearly outweigh undesirable effects, or vice versa. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Single randomized controlled trial or well-designed observational study with strong evidence; or well-designed cohort or case&amp;ndash;control analytic study; or multiple time series or dramatic results of uncontrolled experiment. Desirable effects closely balanced with undesirable effects. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;At least one well-designed, nonexperimental descriptive study (e.g., comparative studies, correlation studies, case studies) or expert committee reports, opinions and/or experience of respected authorities, including consensus from development and/or reviewer groups. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Based on Guyatt GH, Cook DJ, Jaeschke R, et al. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). [published erratum in Chest 2008;34:47]. Chest 2008;133(6 Suppl):123S-131S.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Evaluating the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A Stroke Best Practices Recommendations Matrix was developed that mapped other existing stroke-related recommendations and their levels of evidence onto topic areas identified as relevant to optimal stroke care in Canada (i.e., blood pressure management, organization of care).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A list of topics was generated by identifying recommendations with the highest levels of evidence in each of the reference guidelines. Where similar or related recommendations on a particular topic appeared in more than two guidelines, it was added to the topic list. The final list of topics was then cross-referenced with the Stroke Canada Optimization of Rehabilitation through Evidence (SCORE) and the Canadian Stroke Quality of Care Study (CSQCS) studies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Best Practices Recommendations Matrix was created through an iterative process of review and discussion among the members of the sub-group and the Best Practices and Standards Working Group (BPS-WG) as a whole.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Evaluation of Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Each recommendation included in this document was evaluated against several criteria: strength of the available research evidence to support the recommendation; degree to which the recommendation drives system change or processes of care delivery; overall validity and relevance as a core recommendation for stroke care along the continuum of care. The levels of evidence included in this document are determined through a structured ranking system which measures the strength of the results in a clinical trial or research study. The design of the study (such as a case report for an individual patient or a randomized double-blinded controlled clinical trial) and the endpoints measured (such as survival or quality of life) affect the strength of the evidence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The various types of study designs, in descending order of strength, include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Randomized controlled clinical trials (double-blinded or non-blinded) are considered the gold standard of study design. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Meta-analyses of randomized studies offer a quantitative synthesis of previously conducted studies. The strength of evidence from a meta-analysis is based on the quality of the conduct of individual studies. Meta-analyses of randomized studies are placed in the same category of strength of evidence as are randomized studies. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nonrandomized controlled clinical trials &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Case series: Population-based, consecutive series, consecutive cases (not population-based) or nonconsecutive cases. These clinical experiences are the weakest form of study design, but often they are the only available or practical information. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Several rating systems are used by guideline developers to evaluate the strength of the evidence for their recommendations. These systems vary in the nomenclature used (alphabetical versus numeric), but there is usually reasonable equivalence in the definitions across the levels of evidence. Each recommendation in this document provides the level of evidence for the recommendation (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field), as well as the reference for the Primary Guideline(s) that were adapted or contributed most to the wording of the recommendation.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus (Consensus Development Conference)" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Stroke Guideline Development Framework&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The conceptual framework used to guide the identification, selection, development and updating of the Canadian best practice recommendations was the Practice Guideline Evaluation and Adaptation Cycle of Graham and colleagues. This cycle involves a number of steps that are integral to the guideline development process:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Establishing an interdisciplinary guideline development team &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Establishing a guideline appraisal process using a validated tool &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Systematic searching for existing practice guidelines &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Appraising the quality, currency and content of guideline recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Adopting or adapting guidelines for local use &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Obtaining external expert feedback on the proposed recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Selecting final recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Obtaining official endorsement &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Establishing an ongoing review and update process &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;The methodology for the first edition of the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care (2006)&lt;/em&gt; was based on this framework, and it is applied, with some enhancements, to develop each update. The key activities undertaken in the guideline development process are highlighted below.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Leadership and Participants&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Stroke Strategy (CSS) Best Practices and Standards Working Group has overall responsibility for the development and update process. The 2010 update cycle was led by a subgroup of the Working Group and managed by the Director of Performance and Standards at the Canadian Stroke Network (CSN).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;An interprofessional group of experts in stroke care participated in topic-specific task groups convened to review, draft, and revise recommendation statements for their topic. Recognized experts within the topic area chaired each task group, and members included stroke neurologists, physiatrists, nurses, emergency physicians, paramedics, physical therapists, occupational therapists, dietitians, speech&amp;ndash;language pathologists, pharmacists, stroke survivors, education experts, and professionals from other disciplines as required. This interprofessional approach ensured that all relevant health disciplines for a particular topic area were represented in the development of the recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A national interprofessional consensus panel was convened to provide further input into the recommendations and a final review was conducted by an external group of stroke and methods experts before release.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Identification of Key&amp;nbsp;Topic Areas and Core Reference Guidelines&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The process used to identify key topic areas and core reference guidelines is outlined below.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;An ongoing structured literature review is conducted every two to three months to monitor emerging evidence and new or updated stroke-related guidelines. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Scans of the primary research literature focused on meta-analyses, systematic reviews, randomized trials, quasi-experimental studies, other related guidelines and reports, and Canadian consensus statements by healthcare professional groups &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The strength of the research evidence was graded using a standardized grading system (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field). In some areas, the levels of evidence for a given topic varied among selected guidelines or research papers depending on the nature of the research. The totality of the information for each topic provided a comprehensive understanding of the strength of the evidence, the state of the research, and gaps for future inquiry. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A detailed literature search for international stroke-related guidelines was also undertaken. The Appraisal of Guidelines Research and Evaluation (AGREE) tool was applied to determine the quality of the guidelines. This tool can be used to assess the process of guideline development based on six domains: identification of a clinical area to promote best practice, stakeholder involvement, rigour of development, clarity and presentation, applicability, and editorial independence. Based on the results of the appraisals, several guidelines met the Working Group criteria to be considered as 'reference guidelines' for the development process. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Once the high-quality guidelines were identified, a content review was conducted to identify a list of stroke topic areas that were supported by the highest levels of evidence. A secondary list of topic areas with lower levels of supporting evidence but considered being key system drivers (such as acute diagnostic imaging with computed tomography scans) was also compiled. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Potential topics that emerged from the research and guideline review were compiled into a &quot;Topic Matrix&quot; to allow easy comparison by topic and strength of evidence. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The topic areas and levels of supporting evidence were reviewed and debated by the Working Group. Using a consensus model, a final list of stroke topic areas that were considered most relevant to optimal stroke care in Canada was developed. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Topic areas were assigned to one of eight task groups to develop detailed recommendation statements. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;See Appendix 7 in the original guideline document for a list of guidelines and significant research trials that were considered during the 2010 update process.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Synthesis of Best Practice Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Expert task groups (see Appendix 2 in the original guideline document for a list of task group members) were convened&amp;nbsp;for each segment of the continuum of stroke care, to select relevant recommendations arising from the evidence review and if necessary draft new recommendations based on emerging evidence. Task groups were instructed that recommendations could address structure and/or processes of care at either the system level or the patient level, and that they could be taken directly from other existing guidelines, adapted from one or more guidelines, or written by the task group. Appropriate references were to accompany all recommendation statements derived from evidence or existing guidelines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For the 2010 update, each task group participated in a series of teleconferences between May 2009 and February 2010 to complete their research reviews and develop the recommendations. The&amp;nbsp;Director of Performance and Standards at the CSN participated in all teleconferences to ensure consistency, standardization, and rigour of development across task groups.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See the original guideline document for more information on the recommendation development process.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;National Expert Consensus Process&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Following completion of the task group work, the draft recommendations and supporting information were presented for discussion and decision-making to a broad group of stakeholders at a national expert consensus meeting held in Toronto, Ontario in April, 2010 (see Appendix 3 of the original guideline document for a list of consensus participants). Consensus participants included the Best Practices Working Group, the chairs of each task group, and invited opinion leaders, stroke survivors, and healthcare professionals external to the development process. The selection of consensus participants was based on ensuring representation from stroke-related health professional disciplines, all sectors of the healthcare continuum, all provinces in Canada, and rural and urban work environments.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Consensus participants received the draft recommendations, including proposed changes to existing recommendations as well as new recommendations, in advance of the consensus meeting. They were asked to review the information, provide feedback to the Working Group prior to the meeting, and indicate their degree of support for each recommendation. Votes were taken after each topic area discussion.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Definitions of the levels of evidence (A-C) are provided at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Note from the Canadian Stroke Network/Heart &amp;amp; Stroke Foundation of Canada (CSN/HSFC) and the National Guideline Clearinghouse (NGC)&lt;/strong&gt;: The &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt;, 2010 update, has been divided into individual summaries. In addition to the current summary, the following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34085&quot; title=&quot;Guideline #8610&quot;&gt;Public awareness of stroke&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34087&quot; title=&quot;Guideline #8611&quot;&gt;Prevention of stroke&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34088&quot; title=&quot;Guideline #8612&quot;&gt;Hyperacute stroke management&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34091&quot; title=&quot;Guideline #8614&quot;&gt;Stroke rehabilitation&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34092&quot; title=&quot;Guideline #8615&quot;&gt;Managing stroke care transitions&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34094&quot; title=&quot;Guideline #8616&quot;&gt;Cross-continuum topics in stroke management&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;What's New for 2010?&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The 2010 content update focuses on:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Access: Providing good stroke care, quickly &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Continuity: Helping people move smoothly through the stroke continuum, from symptom onset to diagnosis, treatment, management, and recovery &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For 2010 the SCORE (Stroke Canada Optimization of Rehabilitation through Evidence) recommendations for upper and lower limb have been integrated within the Canadian Best Practice Recommendations for Stroke Care. Also new for 2010 is a section on transitions of care to help patients, families, and caregivers access the right type of care in the right settings at the right time. To facilitate uptake of the best practice recommendations by front-line clinicians, the best practice recommendations also include a new section on information about implementation resources.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Other significant changes for 2010:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Atrial fibrillation and carotid endarterectomy recommendations were revised to address the findings of two recently published clinical trials (RE-LY and CREST), which have important implications for stroke prevention. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Intracranial hemorrhage and subarachnoid hemorrhage recommendations were revised and expanded to address immediate assessment and management of these patients. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;New recommendations on fall prevention to address an important patient safety issue &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Acute Stroke Management&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Stroke Unit Care&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients admitted to hospital because of an acute stroke or transient ischemic attack should be treated on an interprofessional stroke unit [&lt;strong&gt;Evidence Level A&lt;/strong&gt;].&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients should be admitted to a stroke unit which is a specialized, geographically defined hospital unit dedicated to the management of stroke patients [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The core interprofessional team on the stroke unit should consist of healthcare professionals with stroke expertise from medicine, nursing, occupational therapy, physiotherapy, speech&amp;ndash;language pathology, social work and clinical nutrition (dietitian) [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. Additional disciplines may include pharmacy, (neuro)psychology, and recreation therapy [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The interprofessional team should assess patients within 48 hours of admission to hospital and formulate a management plan [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinicians should use standardized, valid assessment tools to evaluate the patient's stroke-related impairments and functional status [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Any child admitted to hospital with stroke should be managed in a centre with paediatric stroke expertise and/or managed using standardized paediatric stroke protocols [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;Refer to the NGC summary of the CSN/HSFC guideline &lt;a href=&quot;/content.aspx?id=34091&quot; title=&quot;Guideline #8614&quot;&gt;Stroke Rehabilitation&lt;/a&gt; for information on inpatient stroke rehabilitation, which should commence in the acute care hospital.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Stroke unit care reduces the likelihood of death and disability by as much as 30 percent for men and women of any age with mild, moderate, or severe stroke. Stroke unit care is characterized by a coordinated interprofessional team approach for preventing stroke complications, preventing stroke recurrence, accelerating mobilization and providing early rehabilitation therapy. Evidence suggests that stroke patients treated on acute stroke units have fewer complications, earlier mobilization, and pneumonia is recognized earlier. Patients should be treated in a geographically defined unit, as roving stroke teams do not provide the same benefit as stroke units.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Prevention and Management of Complications Following Acute Stroke&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Venous thrombo-embolism risk, temperature, mobilization, continence, nutrition, and oral care should be addressed in all hospitalized stroke patients. Appropriate management strategies should be implemented for areas of concern identified during screening. Discharge planning should be included as part of the initial assessment and ongoing care of acute stroke patients.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Venous Thromboembolism Prophylaxis&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;All stroke patients should be assessed for their risk of developing venous thromboembolism (deep vein thrombosis and pulmonary embolism). Patients at high risk include those who are unable to move one or both lower limbs and those who are unable to mobilize independently; a previous history of venous thromboembolism; dehydration; and comorbidities such as malignant disease.&lt;/p&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Early mobilization and adequate hydration should be encouraged for all acute stroke patients to help prevent venous thromboembolism [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patients at high risk of venous thromboembolism should be started on venous thromboembolism prophylaxis immediately [&lt;strong&gt;Evidence Level A&lt;/strong&gt;].&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Low molecular weight heparin should be considered for patients with acute ischemic stroke at high risk of venous thromboembolism; or unfractionated heparin for patients with renal failure [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;The use of anti-embolism stockings alone for post-stroke venous thrombo-embolism prophylaxis is not recommended [&lt;strong&gt;Evidence Level A&lt;/strong&gt;] (CLOTS Trials Collaboration et al., 2009). &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;3&quot;&gt;&#xD;&#xA;        &lt;li&gt;There is insufficient evidence on the safety and efficacy of anticoagulant deep vein thrombosis prophylaxis after intracerebral hemorrhage [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. Antithrombotics and anticoagulants should be avoided for at least 48 hours after onset [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Temperature Management&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Temperature should be monitored as part of routine vital sign assessments, every four hours for first 48 hours and then as per ward routine or based on clinical judgment [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;For temperature greater than 37.5&amp;deg; Celsius, increase frequency of monitoring, initiate temperature-reducing measures, investigate possible infection such as pneumonia or urinary tract infection [&lt;strong&gt;Evidence Level C&lt;/strong&gt;], and initiate antipyretic and antimicrobial therapy as required [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;3&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Mobilization&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;&lt;em&gt;Mobilization is defined as &quot;the process of getting a patient to move in the bed, sit up, stand, and eventually walk&quot;&lt;/em&gt; (Veterans Affairs/Department of Defense, 2003).&lt;/p&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All patients admitted to hospital with acute stroke should be mobilized as early and as frequently as possible [&lt;strong&gt;Evidence Level B&lt;/strong&gt;], and preferably within 24 hours of stroke symptom onset, unless contraindicated [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. Some contraindications to early mobilization include, but may not be restricted to, unstable medical conditions, low oxygen saturation, and lower limb fracture or injury (Sorbello et al., 2009). &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;All patients admitted to hospital with acute stroke should be assessed by rehabilitation professionals as soon as possible after admission [&lt;strong&gt;Evidence Level A&lt;/strong&gt;], preferably within the first 24 to 48 hours [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. Refer to the NGC summary of the CSN/HSFC guideline &lt;a href=&quot;/content.aspx?id=34091&quot; title=&quot;Guideline #8614&quot;&gt;Stroke Rehabilitation&lt;/a&gt; for additional information. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;4&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Continence&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All stroke patients should be screened for urinary incontinence and retention (with or without overflow), fecal incontinence, and constipation (time and frequency) [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The use of a portable ultrasound is recommended as the preferred noninvasive painless method for assessing post-void residual [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Possible contributing factors surrounding continence management should be assessed, including medications, nutrition, diet, mobility, activity, cognition, environment and communication [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. This should include assessing the stroke patient for urinary tract infections to determine a possible transient cause of urinary retention [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Stroke patients with urinary incontinence should be assessed by trained personnel using a structured functional assessment [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The use of indwelling catheters should be avoided due to the risk of urinary tract infection [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. If used, indwelling catheters should be assessed daily and removed as soon as possible [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. Excellent pericare and infection prevention strategies should be implemented to minimize risk of infections [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;A bladder-training program should be implemented in patients who are incontinent of urine [&lt;strong&gt;Evidence Level C&lt;/strong&gt;], including timed and prompted toileting on a consistent schedule [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Appropriate intermittent catheterization schedules should be established based on amount of post-void residual [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;A bowel management program should be implemented for stroke patients with persistent constipation or bowel incontinence [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;5&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Nutrition and Dysphagia&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;The nutritional and hydration status of stroke patients should be screened within the first 48 hours of admission using a valid screening tool [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Results from the screening process should be used to guide appropriate referral to a dietitian for further assessment and ongoing management of nutritional and hydration status [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Stroke patients with suspected nutritional concerns, hydration deficits, dysphagia, or other comorbidities that may affect nutrition (such as diabetes) should be referred to a dietitian for:&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Recommendations to meet nutrient and fluid needs orally while supporting alterations in food texture and fluid consistency recommended by a speech-language pathologist or other trained professional [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Consideration of enteral nutrition support (tube feeding) within seven days of admission for patients who are unable to meet their nutrient and fluid requirements orally. This decision should be made collaboratively with the interprofessional team, the patient, and the caregivers and family [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. Refer to the NGC summary of the CSN/HSFC guideline &lt;a href=&quot;/content.aspx?id=34092&quot; title=&quot;Guideline #8615&quot;&gt;Managing Stroke Care Transitions&lt;/a&gt; for additional information. &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;6&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Oral Care&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Upon or soon after admission, all stroke patients should have an oral/dental assessment, including screening for signs of dental disease, level of oral care, and appliances [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;For patients wearing a full or partial denture it should be determined if they have the neuromotor skills to safely wear and use the appliance(s) [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;An appropriate oral care protocol should be used for every patient with stroke, including those who use dentures [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. The oral care protocol should be consistent with the Canadian Dental Association recommendations [&lt;strong&gt;Evidence Level B&lt;/strong&gt;], and should address areas such as frequency of oral care (twice per day or more); types of oral care products (toothpaste, floss, and mouthwash); and management for patients with dysphagia (Canadian Dental Association, 2009). &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;If concerns with implementing an oral care protocol are identified, consider consulting a dentist, occupational therapist, speech-language pathologist, and/or a dental hygienist [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;If concerns are identified with oral health and/or appliances, patients should be referred to a dentist for consultation and management as soon as possible [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Acute stroke accounts for one of the longest length of stay of all illnesses in Canadian hospitals and places a significant burden on inpatient resources, which increases further when complications arise. Acute stroke patients are at risk for complications during the early phase of recovery. The priorities for inpatient care are management of stroke sequelae to optimize recovery, prevention of post-stroke complications that may interfere with the recovery process, and prevention of stroke recurrence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Advance Care Planning, Palliative and End-of-Life Care&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Advance Care Planning&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;Patients surviving a stroke and their families should be approached by the stroke healthcare team to participate in advance care planning [&lt;strong&gt;Evidence Level C&lt;/strong&gt;].&lt;/p&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Advance care planning may include identifying a substitute decision-maker (proxy or agent), implementing a personal directive [&lt;strong&gt;Evidence Level C&lt;/strong&gt;], and discussion of the patient's preferences and the medical appropriateness of therapies such as feeding tubes, hydration, treatment of the current illness, admission to intensive care, ventilation, cardiopulmonary resuscitation, and place of care [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The goals of therapy should be revisited periodically and when there is a change in health status [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The interprofessional team should have the appropriate communication skills and knowledge to address the physical, spiritual, psychological, ethical, and social needs of palliative or dying patients and their families [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Palliative and End-of-Life Care&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;The palliative approach should be used with those experiencing significant morbidity after a stroke, or to optimize end-of-life care for dying stroke patients and their families [&lt;strong&gt;Evidence Level B&lt;/strong&gt;].&lt;/p&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Communication with patients and their families should provide, on an ongoing basis, information and counseling regarding diagnosis, prognosis, and management, including:&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;The appropriateness of life-sustaining measures including mechanical ventilation, enteral/intravenous feeding, and intravenous fluids [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Oral care [&lt;strong&gt;Evidence Level C&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Assessment and management of pain [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Assessment and management of delirium [&lt;strong&gt;Evidence Level C&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Assessment and management of respiratory distress [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Assessment and management of incontinence, nausea, vomiting, constipation, and skin and wound care [&lt;strong&gt;Evidence Level C&lt;/strong&gt;] &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;        &lt;li&gt;Patients and the healthcare team should have access to palliative care specialists for consultation on all palliative stroke patients [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Palliative care specialists should be involved in the care of all patients with difficult-to-control symptoms, complex or conflicted end-of-life decision making, or complex psychosocial family issues [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The interprofessional team should have the appropriate communication skills and knowledge to address the physical, spiritual, psychological, and social needs of palliative or dying patients and their families [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Palliative care pathways should be considered to introduce and monitor standards of care provided to palliative or dying stroke patients [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Implementing stroke best practices can contribute to reductions in morbidity and mortality; however, stroke remains the third leading cause of death in Canada. There is evidence of unmet needs in stroke patients who are at the end of life. Recognizing and addressing the needs of the person with a life-limiting stroke or who is close to death after a stroke can enhance the quality of the time left and the satisfaction of the patient, family, caregivers, and the healthcare team.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Summary of Definitions for Levels of Evidence*&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Rating Scheme for the Strength of the Evidence&quot; cellpadding=&quot;3&quot; width=&quot;50%&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Criteria&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Strong recommendation. Evidence from randomized controlled trials or meta-analyses of randomized controlled trials. Desirable effects clearly outweigh undesirable effects, or vice versa. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Single randomized controlled trial or well-designed observational study with strong evidence; or well-designed cohort or case&amp;ndash;control analytic study; or multiple time series or dramatic results of uncontrolled experiment. Desirable effects closely balanced with undesirable effects. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;At least one well-designed, nonexperimental descriptive study (e.g., comparative studies, correlation studies, case studies) or expert committee reports, opinions and/or experience of respected authorities, including consensus from development and/or reviewer groups. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Based on Guyatt GH, Cook DJ, Jaeschke R, et al. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). [published erratum in Chest 2008;34:47]. Chest 2008;133(6 Suppl):123S-131S.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="98" OrdBy="605" ID="425" Name="References Supporting the Recommendations" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Canadian Dental Association. Optimal oral health for frail older adults: best practice along the continuum of care. Ottawa (Ontario): Canadian Dental Association; 2009. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;CLOTS Trials Collaboration, Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, Rudd A, Bowler G. Effectiveness of thigh-length graduated compression stockings to reduce the risk  of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009 Jun 6;373(9679):1958-65. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19477503&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Sorbello D, Dewey HM, Churilov L, Thrift AG, Collier JM, Donnan G, Bernhardt J. Very early mobilisation and complications in the first 3 months after stroke: further results from phase II of A Very Early Rehabilitation Trial (AVERT). Cerebrovasc Dis. 2009;28(4):378-83. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19641313&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Veterans Affairs, Department of Defense, Office of Quality Performance. Veterans Affairs/Department of Defense clinical practice guideline for management of stroke rehabilitation. Washington (DC): US Department of Veterans Affairs; 2003. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of evidence is specifically stated for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This document is the result of an extensive review of international stroke research and published evidence-based best practice recommendations or guidelines related to stroke.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Stroke unit care reduces the likelihood of death and disability by as much as 30 percent for men and women of any age with mild, moderate, or severe stroke. Evidence suggests that stroke patients treated on acute stroke units have fewer complications, earlier mobilization, and pneumonia is recognized earlier. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Appropriate management of stroke sequelae to optimize recovery, prevention of post-stroke complications that may interfere with the recovery process, and prevention of stroke recurrence &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Implementing stroke best practices can contribute to reductions in morbidity and mortality. Recognizing and addressing the needs of the person with a life-limiting stroke or who is close to death after a stroke can enhance the quality of the time left and the satisfaction of the patient, family, caregivers, and the healthcare team. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Subcutaneous heparin and low-molecular-weight heparin are associated with increased risk of intracranial hemorrhage.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="430" OrdBy="800" Name="Contraindications"><Field FieldID="144" OrdBy="805" ID="431" Name="Contraindications" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Some contraindications to early mobilization include, but may not be restricted to, unstable medical conditions, low oxygen saturation, and lower limb fracture or injury.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The Canadian Stroke Strategy (CSS) recognizes that human, financial, and system resource limitations may make it difficult to implement all recommendations in this document. However, the recommendations and performance measures are presented as &quot;gold standard&quot; benchmarks toward which all organizations and systems should strive. Additionally, these recommendations can be valuable tools and information sources for anyone advocating for improved stroke care services. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The recommendations in this document are better seen as guidelines rather than rigid rules. They are not meant to supplant clinical judgment and consideration of unique patient circumstances. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Every attempt has been made to keep these recommendations up to date; however, given the rapid evolution of stroke research, late-breaking evidence may not be reflected. For this update, the literature review completion date was September 30, 2010. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It was not feasible to present the expert panel with all available evidence, and therefore the primary evidence was initially screened and evaluated by the task groups. Wherever possible, late-breaking evidence was reviewed by the task group leaders to identify areas where the current recommendations might be significantly altered. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Networking and Distribution&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Stroke Strategy (CSS) makes the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt; available openly and at no cost, in English and French. Publication and dissemination strategies have changed in response to user needs and feedback. In 2006, printed documents and CDs were provided to all contacts in the CSS database, to others on request, and to interested groups throughout Canada and internationally. The 2008 Update was published through the &lt;em&gt;Canadian Medical Association Journal&lt;/em&gt; (CMAJ) as a supplement to subscribers and posted on the CMAJ website with links to the document on the CSS website; the CSS provided a limited number of printed copies upon request. The 2010 Update is available on the Canadian Stroke Network (CSN) Best Practices web site, at &lt;a href=&quot;http://www.strokebestpractices.ca/&quot; title=&quot;CSN Web site&quot;&gt;www.strokebestpractices.ca&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Also on the website, patients and the general public can find &lt;em&gt;A Patient's Guide to the Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt;. The CSS created the patient's guide in recognition of the fact that the best practice recommendations are lengthy and written primarily for a healthcare audience.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The CSS encourages provincial or territorial and regional stroke strategies to adopt the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt; in their entirety. While the process and speed of implementation will vary depending on circumstances, the vision of offering integrated, high quality, and efficient stroke services to all Canadians should be shared and supported across the country.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The CSS disseminates the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt; by:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Posting the recommendations on the Canadian Stroke Network Best Practices website and other central guideline repository websites such as the World Stroke Organization website, the National Guideline Clearinghouse, the Internet Stroke Centre, and the Canadian Medical Association website &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Writing feature articles for publications such as the &lt;em&gt;Canadian Medical Association Journal&lt;/em&gt; and the Canadian Stroke Network &lt;em&gt;Brainwaves&lt;/em&gt; newsletter &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Alerting all contacts in the CSS database of Updates and how to access them &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Encouraging others to set up electronic links to the recommendations (e.g., Canadian Stroke Network, Heart and Stroke Foundation of Canada, provincial stroke strategies) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Sharing details with all the CSS working groups to ensure alignment and collaboration in dissemination &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Engaging provincial stroke champions through presentations and discussion &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Consulting other national guideline groups in related fields (e.g., hypertension, dyslipidemia, diabetes) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Presenting at national, provincial, and regional meetings of healthcare professionals across healthcare disciplines and across the continuum of stroke care &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Making presentations to front-line healthcare professionals at the local level and using local consensus processes to review and provide structured assessment of the enablers and barriers to guideline implementation, as well as innovative implementation strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;E-mailing key stakeholders and front-line healthcare professionals working with persons with stroke and their families throughout the continuum of stroke care &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Highlighting specific recommendations in stroke-related newsletters such as the National Stroke Nursing Council's newsletter &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Disseminating the recommendations at international stroke meetings through the World Stroke Organization, the Guidelines International Network, and international partners and collaborators &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;The CSS encourages provincial or territorial and regional stroke strategy leaders to use these or other applicable approaches to further disseminate the recommendations and supporting tools to healthcare professionals, health system planners, decision-makers, and funders.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Tools to Support Implementation of the Best Practice Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The national professional development and training platform of the CSS focuses on developing and implementing an integrated professional development and training plan for stroke professionals who care for patients, families, and caregivers. Professional development and training activities are carried out by a sub-group of the Best Practices and Standards Working Group, using a three-pronged approach that encompasses pre-professional education, professional development, and systems change.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Several point-of-care tools have been developed and are available through the websites of the CSN at &lt;a href=&quot;http://www.strokebestpractices.ca/&quot; title=&quot;CSN Web site&quot;&gt;www.strokebestpractices.ca&lt;/a&gt; and the Heart and Stroke Foundation of Canada at &lt;a href=&quot;http://www.heartandstroke.com/&quot; title=&quot;Heart and Stroke Foundation of Canada Web site&quot;&gt;www.heartandstroke.com&lt;/a&gt;. These tools address pre-hospital care, acute stroke care, stroke unit care, prevention, and long-term care (refer to Appendix 8 of the original guideline document for a list of professional development resources). The target audiences for each tool vary, but generally these tools are relevant to all interprofessional team members in a given setting.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See the original guideline document for System Implication Categories and Performance Measures Development.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Audit Criteria/Indicators" /><FieldValue Value="Foreign Language Translations" /><FieldValue Value="Patient Resources" /><FieldValue Value="Resources" /><FieldValue Value="Staff Training/Competency Material" /><FieldValue Value="Tool Kits" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="End of Life Care" /><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /><FieldValue Value="Timeliness " /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Acute stroke management. In: Lindsay MP, Gubitz G, Bayley M, Hill MD, Davies-Schinkel C, Singh S, Phillips S, Canadian Stroke Strategy Best Practices and Standards Writing Group. Canadian best practice recommendations for stroke care. Ottawa (ON): Canadian Stroke Network; 2010 Dec 8. p. 85-98.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2006 (revised 2010 Dec 8)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Canadian Stroke Network - Disease Specific Society" /><FieldValue Value="Heart and Stroke Foundation of Canada - Disease Specific Society" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The development of these Canadian stroke care guidelines is funded in its entirety by the Canadian Stroke Strategy, a joint initiative of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. The Canadian Stroke Strategy is funded primarily by the Canadian Stroke Network, which is in turn funded by the Networks of Centres of Excellence program.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;No funds for the development of these guidelines come from commercial interests, including pharmaceutical companies.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Canadian Stroke Strategy Best Practices and Standards Working Group&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Working Group Members&lt;/em&gt;: Stephen Phillips (&lt;em&gt;Co-Chair&lt;/em&gt;), Director, Acute Stroke Program, Queen Elizabeth II Health Sciences Centre, Nova Scotia; Mark Bayley (&lt;em&gt;Co-Chair&lt;/em&gt;), Physiatrist and Medical Director, Neuro Rehabilitation Program, Toronto Rehabilitation Institute, Ontario; Gord Gubitz, Lead, 2010 Best Practices Update; Neurologist, Acute Stroke Unit and Outpatient Neurovascular Clinic, Queen Elizabeth II Health Sciences Centre, Nova Scotia; Laurie Cameron, Program Coordinator &amp;amp; Executive Assistant, Canadian Stroke Strategy; Corrine Davies-Schinkel, Project Coordinator, Canadian Stroke Network; Michelle Edwards, Occupational Therapist, Foothills Medical Centre, Alberta; Ian Graham, Vice-President, Knowledge Translation, Canadian Institutes of Health Research; Mary Elizabeth Harriman, Associate Executive Director, Heart and Stroke Foundation of Canada; Anthony Herd, CAEP Representative, Emergency Physician, Winnipeg Regional Health Authority, Manitoba; Linda Kelloway, Best Practices Lead, Ontario Stroke Network, Ontario; Katie Lafferty, Executive Director, Canadian Stroke Network; Louise-H&amp;eacute;l&amp;egrave;ne LeBrun, Directeur du Centre des maladies vasculairesc&amp;eacute;r&amp;eacute;brales du CHUM, Centre Hospitalier de l'Universit&amp;eacute; de Montr&amp;eacute;al (CHUM), Quebec; Patrice Lindsay, Staff Lead, Director of Performance and Standards, Canadian Stroke Network; Samantha Singh, Project Coordinator, Canadian Stroke Network; Elizabeth Woodbury, Executive Director, Canadian Stroke Strategy&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Participants in the development and review process are required to sign confidentiality agreements and to declare all potential conflicts of interest in writing. Only seven out of 143 participants declared a minor conflict such as receipt of honoraria to speak about stroke in other venues. None of these conflicts were deemed to prevent unbiased participation in the process. The recommendations were approved following a rigorous development process and through a consensus of independent experts and stakeholders, thereby minimizing the potential influence of any one participant. See Appendices 1, 2, 3, and 4 in the original guideline document for complete statements of competing interests.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S. Canadian best practice recommendations for stroke care. CMAJ 2008 Dec 2;179(12 Suppl).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Best Practice Recommendations for Stroke Care include an ongoing plan to formally update the recommendations every 2 years to ensure that the best practice recommendations remain current and are coordinated with other similar initiatives nationally and internationally.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/04/2010BPR_ENG.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/04/2010BPR_FRENCH.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Canadian Best Practice Recommendations for Stroke Care: 2008 toolkit. Available in English and French from the &lt;a href=&quot;http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.5398033/k.2C15/Canadian_Best_Practices_Workshop.htm&quot; title=&quot;Heart and Stroke Foundation of Ontario Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Ontario Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Secondary prevention best practice workshop tool kit: preventing strokes one at a time. Available from the &lt;a href=&quot;http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.5882219/k.48F5/Secondary_Prevention_Tool_Kit.htm&quot; title=&quot;Heart and Stroke Foundation of Ontario Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Ontario Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Acute stroke management workshop. Available in English and French from the &lt;a href=&quot;http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.5346923/k.8D25/HCP__English.htm&quot; title=&quot;Heart and Stroke Foundation of Ontario Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Ontario Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Canadian Best Practice Recommendations for Stroke Care: educational workshop for emergency medical care of suspected acute care patients. Available in Portable Document Format (PDF) in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS_EMS-Stroke-Wksp_FINAL.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS_EMS_fr.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Canadian Stroke Strategy performance measurement manual: a supplement to the Canadian best practice recommendations for stroke care. 2008 May. 48 p. Electronic copies: Available in PDF in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Performance-Manual-2008_EN.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Performance-Manuel-2008_FR.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Canadian Stroke Strategy core performance indicator update 2010. 2010 Jun. 8 p. Electronic copies: Available in PDF in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/12/Stroke_Core_ENG.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/12/Stroke_Core_FRE.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A guide to the implementation of stroke unit care. A resource for implementation of Canadian Best Practice Recommendations for Stroke Care. 2009 Dec. 24 p. Available in PDF in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Stroke-Unit-Resource_EN-Final2-for-print.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Stroke-Unit-Resource_FR3-Final-for-print.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Additional resources are available in &lt;a href=&quot;http://www.strokebestpractices.ca/index.php/resources/&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/index.php/resources/?lang=fr&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Best Practices Web site.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;A patient's guide to Canadian best practice recommendations for stroke care. 2011. 8 p. Electronic copies: Available in Portable Document Format (PDF) in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/11/CSN_PatientsGuide2011_English_WEB11.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/11/CSN_PatientsGuide2011_French_WEB21.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Best Practices Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Getting on with the rest of your life after stroke: a guide for patients and their families. 68 p. Electronic copies: Available in PDF in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/09/GettingOn2-EN.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/French-Getting-On.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A family guide to pediatric stroke. 2011. 34 p. Electronic copies: Available in Portable Document Format (PDF) in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/10/PEDSGuide-EN.pdf&quot; title=&quot;Canadian Stroke Network Best Practices Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/10/PEDSGuide-FR.pdf&quot; title=&quot;Canadian Stroke Network Best Practices Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Best Practices Web site. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Additionally, a variety of patient information resources, including a list of stroke warning signs, is available from the &lt;a href=&quot;http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483933/&quot; title=&quot;Heart and Stroke Foundation of Canada Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Canada Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on July 14, 2008. The information was verified by the guideline developer on August 27, 2008. This NGC summary was updated by ECRI Institute on December 1, 2009. This NGC summary was updated by ECRI Institute on December 1, 2011. The updated information was verified by the guideline developer on January 9, 2012. This summary was updated by ECRI Institute on March 10, 2014 following the U.S. Food and Drug Administration advisory on Low Molecular Weight Heparins.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
